TMCnet News

Evogene to Hold Virtual Investor & Analyst Days
[April 07, 2021]

Evogene to Hold Virtual Investor & Analyst Days

REHOVOT, Israel, April 7, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN), a leading computational biology company today announced that it will hold virtual investor and analyst days, in both Hebrew and English, via Zoom webinars.

Evogene Logo

The meetings will feature key-note presentations from Evogene's CEO, Ofer Haviv, and the CEOs of Evogene group subsidiaries Biomica, Canonic, AgPlenus, and Lavie Bio, followed by a question and answer session.


Questions to the speakers may be sent in advance of the event via the registration link or to or may be sent via the Question and Answer link in the zoom webinar during the event.

About Evogene Ltd.:

Evogene (NASDAQ: EVGN), (TASE: EVGN) is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its broadly applicable Computational Predictive Biology (CPB) platform.  The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules and genetic elements.  Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., and ag-solutions for castor oil production through Casterra Ltd.


Evogene Investor Contact:

US Investor Relations:

Rivka Neufeld / Aviva Banczewski 

Joseph Green

Investor Relations

Edison Group



T: +972-8-931-1900

T: +1 646-653-7030

Laine Yonker

Edison Group


T: +1 646-653-7035

Cision View original content:

SOURCE Evogene

[ Back To's Homepage ]